FDA Warning Letter — Exxon 393

Case 694259 — FEI 3029257387

The FDA took a Warning Letter action against Exxon 393 on Nov 21, 2024 (Scranton, PA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon 393
Date
Nov 21, 2024
Fiscal Year
2025
Product Type
Tobacco
Center
CTP
Location
Scranton, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.